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DOI: 10.1039/c2nr30768eWe report the investigation of the mechanical properties of different
types of amyloid fibrils by the peak force quantitative nano-
mechanical (PF-QNM) technique. We demonstrate that this tech-
nique correctly measures the Young’s modulus independent of the
polymorphic state and the cross-sectional structural details of the
fibrils, and we show that values for amyloid fibrils assembled from
heptapeptides, a-synuclein, Ab(1–42), insulin, b-lactoglobulin,
lysozyme, ovalbumin, Tau protein and bovine serum albumin all fall
in the range of 2–4 GPa.Introduction
The study of the self-assembly of peptides and unfolded proteins into
highly ordered fibrillar nanostructures, referred to as ‘‘amyloid fibrils’’
and characterised by a dominant b-sheet secondary structure, is
a quickly growing field due to its relevance in biology, medicine,
biophysics, andmaterials science. Themain source of interest in these
systems is due to their association with a number of neurodegener-
ative and pathological human diseases such as Parkinson’s, Alz-
heimer’s, Creutzfeldt–Jakob diseases and type II diabetes.1–5
However, occurrence of amyloid fibrils with normal biological
activities unrelated to diseases is also found in nature: these systems
are referred to as ‘‘functional amyloid fibrils’’.6–8 In addition, the
ability of a wide range of disease-unrelated proteins and artificial
peptides to form amyloid-like structures in vitromakes amyloid fibrils
very good candidates in food, biomedical, and nanotechnology
applications.9–11 Amyloid fibrils exhibit remarkable mechanical
properties with values of Young’s moduli in the order of several GPa
due to the strong ordering of hydrogen bonds between the b-
sheets.11–13For instance, insulin has been shown to possess a Young’s
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4426 | Nanoscale, 2012, 4, 4426–4429The assessment of mechanical and structural properties at the
single fibril level provides very important information for the under-
standing of the role of amyloid fibrils in a biological context, and can
allow tuning their functionality in nanomaterials applications. For
example, with respect to the biological role of amyloid fibrils, it is now
established that fibril fragmentation can enhance cytotoxicity.14 To
this end, both experimental and theoretical approaches have been
considered. Atomic force microscopy (AFM) represents one of the
most suitable experimental techniques for quantitative measurements
of local elasticity of fibrils, due to the possibility of imaging at the
single molecule level12,15,16 and imposing and measuring forces down
to the piconewton range,13,17 although indirect procedures are typi-
cally required to extract intrinsic mechanical properties. On the other
hand, estimations ofYoung’smoduli of amyloid fibrils by simulations
point at numbers in the same order of magnitude as experimental
values, yet, systematically higher.18–21
Recently, we have reported that peak force quantitative nano-
mechanical (PF-QNM) AFM shows great potential to be applied as
a high-resolution technique to identify structural features and asso-
ciated nanomechanical properties of amyloid fibrils.22
Here we further demonstrate that the technique is insensitive to the
structural details of the amyloid fibril cross-section, that is to say that
the intrinsic stiffness expressed by Young’s modulus can be correctly
de-coupled from the overall rigidity, to which both Young’s modulus
and cross-section contribute.We then apply the technique to different
classes of amyloid fibrils, to measure the Young’s modulus for an
end-capped heptapeptide, a-synuclein, Ab(1–42), Tau protein,
insulin, b-lactoglobulin, lysozyme, ovalbumin and bovine serum
albumin fibrils and we show that all values of Young’s moduli are in
the range of 2–4 GPa.Materials and methods
Amyloid fibrils preparation
All the amyloid fibrils were produced in vitro according to established
protocols. Below, we give only a short experimental summary,
addressing the reader to individual published procedures for more
details. The peptide CH3CONH-bAbAKLVFF-CONH2 (Mw
835.93 Da) was custom-synthesized by C.S. Bio Company (USA)
and used as received, without further purification and 0.5 wt%
solution was prepared by dilution of the peptide inMilli-Q water.23,24This journal is ª The Royal Society of Chemistry 2012
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View Article OnlineBioPURE-b-lactoglobulin25 was obtained from Davisco Foods
International, Inc. (Le Sueur, MN). Hen egg white lysozyme,26,27
ovalbumin from chicken egg white, bovine serum albumin and
insulin were purchased from Sigma. All proteins were dialyzed for
one week at 4 C against pH 2Milli-Q water and freeze-dried. 2 wt%
protein solutions, prepared in Milli-Q water at pH 2, were placed in
an oil bath at 90 Cand incubatedwithmagnetic agitation (300 rpm).
Aliquots were taken at the given times ranging from 1 to 265 h,
quenched in ice-cold water and stored at 4 C. Ab(1–42),28 a-synu-
clein,29 and tau30 fibrils were grown at 37 C in physiological buffers.Sample preparation
All solutions containing amyloid fibrils were diluted to a final protein
concentration of 0.1 wt% in pH 2 Milli-Q water. A 20 mL aliquot of
each solution was deposited onto freshly cleaved mica, in case of
Ab(1–42) on modified mica,31 incubated for 2 minutes, rinsed with
Milli-Q water and dried by air.PF-QNM experiments
PF-QNMmeasurements were performed by using aMultiModeVIII
Scanning Probe Microscope (Bruker, USA) operated in intermittent
mode under ambient conditions at a scan rate of 1 Hz. The micro-
scope was covered with an acoustic hood to minimize vibrational
noise. The AFM cantilevers (Bruker, USA) were calibrated on the
calibration samples (Bruker, USA) – typically low-densityFig. 1 AFM height images of (a) twisted ribbon, (b) helical ribbon and (c
bAbAKLVFF-CONH2. Schematic presentation of (d) twisted ribbon and (e)
curve), helical ribbon (red curve) and nanotubes (blue curve).
This journal is ª The Royal Society of Chemistry 2012polyethylene and polystyrene – covering the following ranges of
Young’s moduli: from 100 MPa to 2 GPa (for low-density poly-
ethylene) and from 1 to 20 GPa (for polystyrene).22 The analysis of
the Derjaguin–Mueller–Toporov (DMT)modulus was performed by
the software Nanoscope Analysis.
Results and discussion
The overall rigidity or flexibility of amyloid fibrils is well described by
the persistence length lp, which is the typical length at which thermal
fluctuations begin to bend the fibril in different directions. The
persistence length encodes the intrinsic stiffness of the fibril and the
geometry of its cross-section, correlated by the relation lp ¼ EI/kBT,
where E is the Young’s modulus of the fibril, I is the area moment of
inertia of the fibril cross-section, kB is the Boltzmann constant and T
is the temperature.
Amyloid fibrils are often composed of several protofilaments.
Therefore the area moment of inertia I depends specifically on the
packing geometry of individual protofilaments and the number of
protofilaments in mature fibrils.32 When the exact packing scheme of
the different protofilaments within the same amyloid fibril is estab-
lished and the value of the persistence length can be measured, the
precise estimation of the Young’s modulus of the amyloid fibril can
be determined. This approach has been successfully employed to
determine the Young’s modulus of b-lactoglobulin fibrils, for which
the packing schemes of the protofilaments are nowwell-established.15
A first success of the PF-QNM method has been to show that the) nanotube-like structures of the end-capped heptapeptide CH3CONH-
nanotube-like structures. (f) The height profiles of twisted ribbon (black
Nanoscale, 2012, 4, 4426–4429 | 4427
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View Article Onlinemeasured values of Young’s modulus and those extracted by this
indirect procedure were in excellent agreement.22
This indirectly points to another very important issue in amyloid
fibrils, that is, different polymorphic amyloid forms of the same
protein or peptide should possess different area moments of inertia,
different persistence lengths, but identical Young’s moduli. Although
this is often assumed in the literature, a direct, experimental evidence
has not been given, to the best of our knowledge. In principle, PF-
QNM should allow for an assessment of this open question, due to
the direct measurement of the intrinsic stiffness.
To move forward we need to apply PF-QNM to an amyloid
system showing a high level of polymorphic structures. It has been
recently shown that the end-capped heptapeptide CH3CONH-
bAbAKLVFF-CONH2, modified from the Ab(16–20) fragment
KLVFF,23 assembles upon incubation into different morphologies of
amyloid fibrils from twisted ribbons to helical ribbons and finally to
nanotube-like structures.24
Due to the different area moment of inertia I for the three packing
schemes we do expect a different persistence length for the three
structures, whichwe estimate (fromfibrils with identical height profile
and same maximum height), using the bond correlation function
hcosq(s)i ¼ exp(s/2lp) where q is the angle between the tangentFig. 2 AFM height image of (a) twisted ribbon, (d) helical ribbon and (g
bAbAKLVFF-CONH2. AFMDMTmodulus image of (b) twisted ribbon, (e)
positions at which the DMTmodulus was analysed. Profiles of DMTmoduli a
The data were obtained by analysis of 20 fibrils for each type.
4428 | Nanoscale, 2012, 4, 4426–4429vectors to the chain at two points separated by a contour distance s
and the factor 2 is used to rescale the exponential decay accounting
for the two-dimensional nature of fibrils absorbed on a substrate.32,33
This is justified by our recent findings that amyloid fibrils do possess,
at large length scales, the fractal exponent characteristic of self-
avoiding randomwalks in 2D e.g. 3/4, unambiguously demonstrating
equilibration of the fibrils in 2D.27 Indeed, in the case of twisted
ribbons, the fibrils are more flexible and their persistence length lp is
3.5 mm while for the nanotube-like structures lp is 18.5 mm; helical
ribbons provide an interesting intermediate case, with lp of 14.7 mm.
These observations are in perfect agreement with the expected
increase in the rigidity of amyloid fibrils showing twisted ribbons/
nanotubes polymorphism32 (Fig. 1).
We then performed PF-QNM experiments to measure the
Young’s moduli of the modified heptapeptide exhibiting these
differentmorphologies (Fig. 2). In the three cases themeasured values
are identical within the experimental error: for twisted ribbons the
Young’smodulus is found to be 2.3 0.6GPa; for helical ribbons we
measure a value of 2.3 0.7 GPa and for nanotubes 2.4 0.5 GPa.
We show in Fig. 2 the analysis of the Young’s modulus for the three
polymorphic forms twisted ribbons, helical ribbons and nanotube-
like structures.) nanotube-like structures of the end-capped heptapeptide CH3CONH-
helical ribbon and (h) nanotube-like structures. The dashed lines mark the
long (c) twisted ribbon, (f) helical ribbon and (i) nanotube-like structures.
This journal is ª The Royal Society of Chemistry 2012
Table 1 The Young’s moduli of several amyloid fibril types measured by
the PF-QNM technique
Amyloid fibrils Young’s modulus
CH3CONH-bAbAKLVFF-CONH2 2.3  0.6 GPa
Insulin 3.2  0.6 GPa
b-Lactoglobulin 3.7  0.8 GPa
Lysozyme 2.8  0.9 GPa
Bovine serum albumin 3.0  0.6 GPa
Ovalbumim 2.7  0.8 GPa
Tau protein 3.4  0.7 GPa
Ab(1–42) 3.2  0.8 GPa
a-Synuclein 2.2  0.6 GPa
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View Article OnlineWe have thus demonstrated experimentally by PF-QNM that
morphologically different amyloid structures of the same peptide,
characterised by a five-fold difference in rigidity, as expressed by the
persistence length, do possess identical Young’s moduli. These find-
ings have a doubly important relevance: on one hand they offer an
important assessment into amyloid fibrils’ physical properties; on the
other hand they provide an additional solid benchmark for the PF-
QNM method. Having confirmed that PF-QNM can perfectly
disentangle the Young’s modulus from topological details of amyloid
fibrils, we proceeded to the measurement of the Young’s moduli of
several different families of amyloid fibrils, assembled from a-synu-
clein, Ab(1–42), tau protein, insulin, b-lactoglobulin, lysozyme,
ovalbumin and bovine serum albumin fibrils.
The values of the measured Young’s moduli are given in Table 1.
As a comparison with other available data on Young’s modulus of
amyloid fibrils, it is worth noting that the value of Young’s modulus
for insulin amyloid fibrils measured here by PF-QNM is 3.2 
0.6 GPa, which is very similar to the Young’s modulus of insulin
reported elsewhere (3.3  0.4 GPa).13 More importantly, the values
we measure for a-synuclein fibrils are nearly identical to the values of
Young’s modulus independently measured by the PF-QNM by the
group of Subramaniam and colleagues.34Conclusions
By performing PF-QNM experiments on several kinds of mature
amyloid fibrils we have shown that the values of the Young’s moduli
can be entirely disentangled from the overall rigidities associated with
different polymorphic forms of the fibrils, and their different area
moments of inertia. We have thus demonstrated that the Young’s
modulus measured by PF-QNM correctly identifies the intrinsic
stiffness of the fibril. This has further allowed us to unequivocally
conclude that the self-assembly of the same peptide associating into
different polymorphic forms of amyloid fibrils with twisted ribbon,
helical ribbon and nanotube cross-section always results in the same
Young’s modulus of the fibril, independent of the specific
morphology. We have then measured the Young’s moduli of a wide
range of amyloid fibril classes and benchmarked, when possible, the
measured values with those values available from the literature,This journal is ª The Royal Society of Chemistry 2012showing that all the amyloid classes investigated have Young’s
moduli in the 2–4 GPa range.Notes and references
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